SB431542, a TGF inhibitor, inhibited the effects of IQGAP3 on HCC cell motility and invasion, suggesting that activation of TGF-β signaling is a crucial mediator for IQGAP3-induced HCC metastasis [86]. Here, IQGAP3 is linked to hepatocellular carcinoma.